Sagittarius Life Science Corp reported earnings results for the first quarter ended March 31, 2022. For the first quarter, the company reported sales was TWD 134.35 million compared to TWD 147.47 million a year ago. Net loss was TWD 21.31 million compared to TWD 22.14 million a year ago. Basic loss per share from continuing operations was TWD 0.65 compared to TWD 0.68 a year ago. Diluted loss per share from continuing operations was TWD 0.65 compared to TWD 0.68 a year ago.